Authors

• Hejian Zou (ORCID: https://orcid.org/0000-0001-9762-2663)
• Lie Dai (ORCID: https://orcid.org/0000-0001-6596-8889)
• Lingyun Sun
• Dongzhou Liu
• Cibo Huang (ORCID: https://orcid.org/0000-0001-6706-7750)
• Zhengyu Xiao (ORCID: https://orcid.org/0000-0002-8139-1570)
• Huaxiang Wu (ORCID: https://orcid.org/0000-0003-4242-8438)
• Chunyu Tan (ORCID: https://orcid.org/0009-0004-1068-5995)
• Yan Yan (ORCID: https://orcid.org/0000-0001-5325-6737)
• Zhijun Li (ORCID: https://orcid.org/0000-0002-1378-791X)
• Hongying Li (ORCID: https://orcid.org/0000-0001-7411-819X)
• Jiankang Hu
• Jian Xu
• Jingyang Li (ORCID: https://orcid.org/0000-0001-8271-1575)
• Ning Kong (ORCID: https://orcid.org/0000-0002-9084-0008)

Institutions

• Central South University (CN)
• Sun Yat-sen University (CN)
• Sichuan University (CN)
• Kunming Medical University (CN)
• Shantou University (CN)
• West China Hospital of Sichuan University (CN)
• Sun Yat-sen Memorial Hospital (CN)
• Nanjing Drum Tower Hospital (CN)
• First Affiliated Hospital of Shantou University Medical College (CN)
• Beijing Hospital (CN)
• First Affiliated Hospital of Kunming Medical University (CN)
• Zhuzhou Central Hospital (CN)
• University of Hong Kong - Shenzhen Hospital (CN)
• First Affiliated Hospital of Bengbu Medical College (CN)
• Lilly (China) (CN)
• Second Affiliated Hospital of Zhejiang University (CN)

Publication Details

Journal

Rheumatology and Therapy

Published

2025-05-09

DOI

https://doi.org/10.1007/s40744-025-00765-7

Citations

1

Primary Topic

Spondyloarthritis Studies and Treatments

Type

article

Field-Weighted Citation Impact

1.67

Funders

• Eli Lilly and Company